Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that BRCA1 and BRCA2 testing consists of full sequence and duplication/deletion analysis. 
Genetic testing for a known mutation in a family may be limited to the known familial variant. 
 
The following indications for BRCA1 and BRCA2 testing are covered by Medicare: 
 
Criteria for Testing 
 
    Individual with breast, ovarian1, pancreatic, or prostate cancer from a family with a known deleterious 
BRCA1 or BRCA2 gene mutation 
    Individual with a personal history of ovarian1* cancer 
    Individual with a breast cancer diagnosis meeting any of the following criteria: 
        Diagnosed =45 y 
        Triple negative breast cancer (estrogen receptor (ER) negative, progesterone receptor (PR) negative, and 
human epidermal growth factor receptor 2 (HER2) negative) breast cancer diagnosed = 60 y 
        Diagnosed at 46-50 y with: 
            An additional breast cancer primary 
            =1 first, second, or third degree relative5 with breast cancer at any age, or 
            =1 first, second, or third degree relative5 with prostate cancer (Gleason score =7), or 
            An unknown or limited family history3 
        Breast cancer diagnosed at any age, and 
            =1 first, second, or third degree relative5 with breast cancer =50 y, or 
            =1 first, second, or third degree relative5 with ovarian cancer at any age, or 
            =1 first, second, or third degree relative5 with metastatic prostate cancer or pancreatic cancer at any 
age, or 
            =2 additional diagnoses of breast cancer at any age in patient and/or in close blood relative5, or 
            A first, second, or third degree male relative with breast cancer 
            For an individual of ethnicity associated with higher mutation frequency (e.g. Ashkenazi Jewish4) no 
additional family history may be required. 
        Male breast cancer 
    Personal history of prostate cancer (Gleason score=7) at any age with: 
        =1 first, second, or third degree relative5 with ovarian cancer at any age, or 
        =1 first, second, or third degree relative5 with breast cancer =50 y, or         =1 first, second, or third degree relative5  pancreatic cancer at any age, or 
        =1 first, second, or third degree relative5 with metastatic prostate cancer at any age, or 
        =2 first, second, or third degree relatives5 with breast cancer and/or pancreatic cancer and/or prostate 
cancer (any grad) at any age, or 
        Ashkenazi Jewish ancestry 
    Personal history of pancreatic cancer at any age 
    Personal history of metastatic prostate cancer (radiographic evidence of or biopsy-proven disease) 
    BRCA1/2 pathogenic mutation detected by tumor profiling on any tumor type in the absence of germline 
mutation analysis 
 
You can find this information in the FUTURE RETIREMENT Local Coverage Determination (LCD) MolDX: 
BRCA1 and BRCA2 Genetic Testing L36163. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.